Search terms
Results 1 - 2 of 2 - ordered by :

Vascular effects and safety of dalcetrapib in patients with or at risk of coronary heart disease: the dal-VESSEL randomized clinical trial [...]in spite of marked elevations in HDL-C, the first ...

European Heart Journal, Lüscher, Thomas F., Taddei, Stefano, Kaski, Juan-Carlos, Jukema, J. Wouter, Kallend, David, Münzel, Thomas, Kastelein, John J.P., Deanfield, John E.

Date : 01/04/2012

Aims Oral anticoagulation is considered standard therapy for stroke prevention in atrial fibrillation (AF). Endocardial activation triggers expression of pro-thrombotic mediators including tissue ...

European Heart Journal, Reiner, Martin F., Breitenstein, Alexander, Holy, Erik W., Glanzmann, Martina, Amstalden, Heidi, Stämpfli, Simon F., Bonetti, Nicole R., Falk, Volkmar, Keller, Stephan, ...

Date : 21/03/2017 Item size : 219667 bytes